Egyptian health tech Almouneer raises $3.6M to scale its platform for treating diabetes and obesity
- Obesity and prediabetes affect more than 40% of the population in Africa and the Middle East.
- Almouneer, an Egyptian health tech company, has secured $3.6 million in funding.
- The funding will support the development and expansion of Almouneer's patient-centric, digitally-enabled lifestyle and diabetes management platform.
The funding secured by Almouneer is a significant milestone for the company and reflects the growing recognition of the importance of addressing obesity and prediabetes in Africa and the Middle East. Almouneer's patient-centric platform has the potential to make a positive impact on the lives of thousands of individuals by providing them with access to healthcare providers and tools for managing their conditions. The company's plans for expansion into neighboring markets show its commitment to addressing the healthcare needs of a wider population.
